Herbal complex suppresses telomerase activity in chemo-endocrine resistant cancer cell lines

A herbal complex consisting of Hoelen, Angelicae radix, Scutellariae radix and Glycyrrhizae radix suppressed cell viability and telomerase activity in hormone-refractory and chemo-resistant cancer cell lines, namely poorly differentiated uterine endometrial cancer cell line AN3 CA, adriamycin-resistant breast cancer cell line MCF7/ADR and cisplatin-resistant ovarian cancer cell line A2780. Furthermore, the herbal complex suppressed the expression of the full length of human telomerase reverse transcriptase (hTERT), which is related to telomerase activity. This indicates that the herbal complex can suppress the tumor growth of chemoendocrine resistant cancers, at least in part via suppression of telomerase activity associated with down-regulated hTERT.

Herbal complex (Hoelen, Angelicae Radix, Scuteltariae Radix and Glycycrrhizae Radix); Telomerase activity; AN3 CA; MCF7/ADR; A2780

[1] Haranaka R., Hasegawa R., Nakagawa S., Sakurai A., Satomi N: "Antitumor activity combination therapy with traditional Chinese medicine and OK432 or MMC". J. Biol. Response Mod,fiers, 1998, 7, 77.

[2] Yamada H., Kiyohara H., Cyong J. C., Kojima Y., Kumazawa Y., Otsuka Y.: "Studies on polysaccharides from Angelica acutiloba Part I. Fractionation and biological properties of polysaccharides" Planta. Med., 1984, 50, 163.

[3] Yamada H., Komiyama K., Kiyohara H., Cyong J. C., Hirakawa Y., Otsuka Y.: "Structural characterization and antitumor activity of a pectic polysaccharide from the roots of Angelica acutiloba". Planta. Med., 1990, 56, 182.

[4] Miyamoto K., Kishi N., Koshiura R., Yoshida T., Hatano T., Okuda T.: "Relationship between the structures and the antitumor activities of tannins". Chem. Pharm. Bull., 1987, 35, 814.

[5] Nishino H., Yoshioka K., Iwashima A., Takizawa H., Konishi S., Okamoto H. et al.: "Glycyrrhetic acid inhibits tumor-promoting activity of teleocidin and 12-italic-tetradecanoylphorbold-13-acetate in two-stage mouse skin carcinogenesis". Jpn. J. Cancer Res., 1986, 77, 33.

[6] KimN. W., Piatyszek M. A., Prowse K. R., Harley C. B., West M. D., Ho P. L. C. et al.: "Specific association of human telomerase activity with immortal cells and cancer". Science, 1994, 266, 2011.

[7] Meyerson M., Counter C. M., Eaton E. N., Ellisen L. W., Steiner P., Caddle S. D. et al.: "hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization". Cell, 1997, 90, 785.

[8] Kilian A., Bowtell D. D., Abud H. E., Hime G. R., Venter D. J., Keese P. K. et al.: "Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types". Hum. Mol. Genet., 1997, 6, 201.

[9] Nakamura T. M., Morin G. B., Chapman K. B., Weinrich S. L., Andrews W. H., Linger J. et al.: "Telomerase catalytic subunit homologs from fission yeast and human". Science, 1997, 277, 955.

[10] Takamura M., Kyo S., Kanaya T., Tanaka M., Inoue M.: "Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer". Cancer Res., 1998, 58, 1558.

[11] Kyo S., Kanaya T., Takakura T., Tanaka M., Yamashita A., Inoue H., Inoue M.: "Expression of human telomerase subunit in ovarian malignant, borderline and benign tumors". Int. J. Cancer, 1999, 80, 804.

[12] Ulaner G. A., Hu T. H., Giudice L. C., Hoffman A. R.:'Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts". Cancer Res., 1988, 58, 4168

[13] Yokoyama Y., Takahashi Y., Shinohara A., Lian Z., Wan X., Niwa K., Tamaya T.: "Attenuation of telomerase activity by a hammerhead ribozyme targeting the template region of telomerase RNA in endometrial carcinoma cell". Cancer Res., 1998, 58, 5406.

[14] Yano H., Mizoguchi A., Fukuda K., Haramaki M., Ogasawara S., Momosaki S., Kojiro M.: "The herbal medicine Sho-saiko-to inhibits proliferation of cancer cell line、by inducing apoptosis and arrest at the GO/GI phase". Cancer Res., 1994, 54, 448.

[15] Oniishi Y., Yamaura T., Tauchi K., Sakamoto T., Tsukada K., Nunome S. et al.: "Expression of the anti-metastatic effect induced by Juzen-taiho-to is based on the content of Shimotsu-to constituents". Bio. Pharm. Bull.. 1998, 21, 761.

[16] Mosmann T.: "Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays". J Immunol. Methods, 1983, 65, 55.

[17] Faraoni I., Turriziani M., Masci G., De Vecchis L., Shay J. W., Bonmassar E., Graziani G.: "Decline in telomerase activity as a measure of tumor cell killing by antineoplastic agent in vitro". Clin. Cancer Res., 1997, 3, 579.